Phase
Condition
N/ATreatment
AcrySof multi-piece IOL
AcrySof single-piece IOL
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Subject is implanted with one of the study IOL models between 3 and 5 yearspreviously.
Subject follow-up is expected to be possible during the duration of the study.
Subject or legally authorized representative must be able to understand and sign theIRB/EC approved Informed Consent form. Minor subjects will complete an Assent Form.
Documented medical history and required pre-operative baseline information isavailable for retrospective data collection.
Exclusion
Key Exclusion Criteria:
Subject is participating in a separate investigational drug or device study.
Pregnancy at the time of enrollment.
Study Design
Study Description
Connect with a study center
Centro Oftalmologico Metropolitano
San Juan, 00921
Puerto RicoSite Not Available
Velvet Clinical Research
Burbank, California 91506
United StatesSite Not Available
Levenson Eye Associates
Jacksonville, Florida 32204
United StatesSite Not Available
Virdi Eye Clinic
Rock Island, Illinois 61201
United StatesSite Not Available
SightMD
Babylon, New York 11702
United StatesSite Not Available
Texan Eye
Austin, Texas 78731
United StatesSite Not Available
Chu Eye Institute
Fort Worth, Texas 76107
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.